 | • レポートコード：MRC2-11QY12890 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は泌尿器治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、注射剤）市場規模、用途別（病院、診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別泌尿器治療薬の競争状況、市場シェア ・世界の泌尿器治療薬市場：種類別市場規模 2015年-2020年（経口、注射剤） ・世界の泌尿器治療薬市場：種類別市場規模予測 2021年-2026年（経口、注射剤） ・世界の泌尿器治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、在宅ケア） ・世界の泌尿器治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、在宅ケア） ・北米の泌尿器治療薬市場分析：米国、カナダ ・ヨーロッパの泌尿器治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの泌尿器治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の泌尿器治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの泌尿器治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi S.A.、Astellas Pharma Inc.、Daiichi Sankyo Company Limited、Pfizer Inc.、Bayer AG、Allergan Plc.、Otsuka Pharmaceutical Co., Ltd.、GlaxosmithKline Plc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Urinary Drugs Market
The global Urinary Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Urinary Drugs Scope and Market Size
Urinary Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Urinary Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Urinary Drugs market is segmented into
Oral
Injectables
Segment by Application, the Urinary Drugs market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Urinary Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Urinary Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Urinary Drugs Market Share Analysis
Urinary Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Urinary Drugs business, the date to enter into the Urinary Drugs market, Urinary Drugs product introduction, recent developments, etc.
The major vendors covered:
Sanofi S.A.
Astellas Pharma Inc.
Daiichi Sankyo Company Limited
Pfizer Inc.
Bayer AG
Allergan Plc.
Otsuka Pharmaceutical Co., Ltd.
GlaxosmithKline Plc.
1 Study Coverage
1.1 Urinary Drugs Product Introduction
1.2 Market Segments
1.3 Key Urinary Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Urinary Drugs Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injectables
1.5 Market by Application
1.5.1 Global Urinary Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Urinary Drugs Market Size, Estimates and Forecasts
2.1.1 Global Urinary Drugs Revenue 2015-2026
2.1.2 Global Urinary Drugs Sales 2015-2026
2.2 Global Urinary Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Urinary Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Urinary Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Urinary Drugs Competitor Landscape by Players
3.1 Urinary Drugs Sales by Manufacturers
3.1.1 Urinary Drugs Sales by Manufacturers (2015-2020)
3.1.2 Urinary Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Urinary Drugs Revenue by Manufacturers
3.2.1 Urinary Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Urinary Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Urinary Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Urinary Drugs Revenue in 2019
3.2.5 Global Urinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Urinary Drugs Price by Manufacturers
3.4 Urinary Drugs Manufacturing Base Distribution, Product Types
3.4.1 Urinary Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Urinary Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Urinary Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Urinary Drugs Market Size by Type (2015-2020)
4.1.1 Global Urinary Drugs Sales by Type (2015-2020)
4.1.2 Global Urinary Drugs Revenue by Type (2015-2020)
4.1.3 Urinary Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Urinary Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Urinary Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Urinary Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Urinary Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Urinary Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Urinary Drugs Market Size by Application (2015-2020)
5.1.1 Global Urinary Drugs Sales by Application (2015-2020)
5.1.2 Global Urinary Drugs Revenue by Application (2015-2020)
5.1.3 Urinary Drugs Price by Application (2015-2020)
5.2 Urinary Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Urinary Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Urinary Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Urinary Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Urinary Drugs by Country
6.1.1 North America Urinary Drugs Sales by Country
6.1.2 North America Urinary Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Urinary Drugs Market Facts & Figures by Type
6.3 North America Urinary Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Urinary Drugs by Country
7.1.1 Europe Urinary Drugs Sales by Country
7.1.2 Europe Urinary Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Urinary Drugs Market Facts & Figures by Type
7.3 Europe Urinary Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Urinary Drugs by Region
8.1.1 Asia Pacific Urinary Drugs Sales by Region
8.1.2 Asia Pacific Urinary Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Urinary Drugs Market Facts & Figures by Type
8.3 Asia Pacific Urinary Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Urinary Drugs by Country
9.1.1 Latin America Urinary Drugs Sales by Country
9.1.2 Latin America Urinary Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Urinary Drugs Market Facts & Figures by Type
9.3 Central & South America Urinary Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Urinary Drugs by Country
10.1.1 Middle East and Africa Urinary Drugs Sales by Country
10.1.2 Middle East and Africa Urinary Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Urinary Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Urinary Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description and Business Overview
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Urinary Drugs Products Offered
11.1.5 Sanofi S.A. Related Developments
11.2 Astellas Pharma Inc.
11.2.1 Astellas Pharma Inc. Corporation Information
11.2.2 Astellas Pharma Inc. Description and Business Overview
11.2.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Inc. Urinary Drugs Products Offered
11.2.5 Astellas Pharma Inc. Related Developments
11.3 Daiichi Sankyo Company Limited
11.3.1 Daiichi Sankyo Company Limited Corporation Information
11.3.2 Daiichi Sankyo Company Limited Description and Business Overview
11.3.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daiichi Sankyo Company Limited Urinary Drugs Products Offered
11.3.5 Daiichi Sankyo Company Limited Related Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Corporation Information
11.4.2 Pfizer Inc. Description and Business Overview
11.4.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Inc. Urinary Drugs Products Offered
11.4.5 Pfizer Inc. Related Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Description and Business Overview
11.5.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer AG Urinary Drugs Products Offered
11.5.5 Bayer AG Related Developments
11.6 Allergan Plc.
11.6.1 Allergan Plc. Corporation Information
11.6.2 Allergan Plc. Description and Business Overview
11.6.3 Allergan Plc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allergan Plc. Urinary Drugs Products Offered
11.6.5 Allergan Plc. Related Developments
11.7 Otsuka Pharmaceutical Co., Ltd.
11.7.1 Otsuka Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Otsuka Pharmaceutical Co., Ltd. Description and Business Overview
11.7.3 Otsuka Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Products Offered
11.7.5 Otsuka Pharmaceutical Co., Ltd. Related Developments
11.8 GlaxosmithKline Plc.
11.8.1 GlaxosmithKline Plc. Corporation Information
11.8.2 GlaxosmithKline Plc. Description and Business Overview
11.8.3 GlaxosmithKline Plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxosmithKline Plc. Urinary Drugs Products Offered
11.8.5 GlaxosmithKline Plc. Related Developments
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Corporation Information
11.1.2 Sanofi S.A. Description and Business Overview
11.1.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi S.A. Urinary Drugs Products Offered
11.1.5 Sanofi S.A. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Urinary Drugs Market Estimates and Projections by Region
12.1.1 Global Urinary Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Urinary Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Urinary Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Urinary Drugs Sales Forecast (2021-2026)
12.2.2 North America: Urinary Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Urinary Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Urinary Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Urinary Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Urinary Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Urinary Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Urinary Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Urinary Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Urinary Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Urinary Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Urinary Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Urinary Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Urinary Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Urinary Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Urinary Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Urinary Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Urinary Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Urinary Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Urinary Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Urinary Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Urinary Drugs Market Segments
Table 2. Ranking of Global Top Urinary Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Urinary Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injectables
Table 6. Global Urinary Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Urinary Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Urinary Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Urinary Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Urinary Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Urinary Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Urinary Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Urinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Urinary Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Drugs as of 2019)
Table 15. Urinary Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Urinary Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Urinary Drugs Price (2015-2020) (USD/MT)
Table 18. Urinary Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Urinary Drugs Product Type
Table 20. Date of International Manufacturers Enter into Urinary Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Urinary Drugs Sales Share by Type (2015-2020)
Table 24. Global Urinary Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Urinary Drugs Revenue Share by Type (2015-2020)
Table 26. Urinary Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Urinary Drugs Sales Share by Application (2015-2020)
Table 29. North America Urinary Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Urinary Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Urinary Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Urinary Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Urinary Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Urinary Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Urinary Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Urinary Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Urinary Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Urinary Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Urinary Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Urinary Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Urinary Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Urinary Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Urinary Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Urinary Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Urinary Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Urinary Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Urinary Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Urinary Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Urinary Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Urinary Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Urinary Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Urinary Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Urinary Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Urinary Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Urinary Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Urinary Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Urinary Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Urinary Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Urinary Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Urinary Drugs Sales Market Share by Application (2015-2020)
Table 69. Sanofi S.A. Corporation Information
Table 70. Sanofi S.A. Description and Major Businesses
Table 71. Sanofi S.A. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Sanofi S.A. Product
Table 73. Sanofi S.A. Recent Development
Table 74. Astellas Pharma Inc. Corporation Information
Table 75. Astellas Pharma Inc. Description and Major Businesses
Table 76. Astellas Pharma Inc. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Astellas Pharma Inc. Product
Table 78. Astellas Pharma Inc. Recent Development
Table 79. Daiichi Sankyo Company Limited Corporation Information
Table 80. Daiichi Sankyo Company Limited Description and Major Businesses
Table 81. Daiichi Sankyo Company Limited Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Daiichi Sankyo Company Limited Product
Table 83. Daiichi Sankyo Company Limited Recent Development
Table 84. Pfizer Inc. Corporation Information
Table 85. Pfizer Inc. Description and Major Businesses
Table 86. Pfizer Inc. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Inc. Product
Table 88. Pfizer Inc. Recent Development
Table 89. Bayer AG Corporation Information
Table 90. Bayer AG Description and Major Businesses
Table 91. Bayer AG Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Bayer AG Product
Table 93. Bayer AG Recent Development
Table 94. Allergan Plc. Corporation Information
Table 95. Allergan Plc. Description and Major Businesses
Table 96. Allergan Plc. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Allergan Plc. Product
Table 98. Allergan Plc. Recent Development
Table 99. Otsuka Pharmaceutical Co., Ltd. Corporation Information
Table 100. Otsuka Pharmaceutical Co., Ltd. Description and Major Businesses
Table 101. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Otsuka Pharmaceutical Co., Ltd. Product
Table 103. Otsuka Pharmaceutical Co., Ltd. Recent Development
Table 104. GlaxosmithKline Plc. Corporation Information
Table 105. GlaxosmithKline Plc. Description and Major Businesses
Table 106. GlaxosmithKline Plc. Urinary Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. GlaxosmithKline Plc. Product
Table 108. GlaxosmithKline Plc. Recent Development
Table 109. Global Urinary Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Urinary Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Urinary Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Urinary Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Urinary Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Urinary Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Urinary Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Urinary Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Urinary Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Urinary Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Urinary Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Urinary Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Urinary Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Urinary Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Urinary Drugs Players
Table 127. Urinary Drugs Customers List
Table 128. Urinary Drugs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Urinary Drugs Product Picture
Figure 2. Global Urinary Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injectables Product Picture
Figure 5. Global Urinary Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Home Care
Figure 9. Urinary Drugs Report Years Considered
Figure 10. Global Urinary Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Urinary Drugs Sales 2015-2026 (K MT)
Figure 12. Global Urinary Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Urinary Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Urinary Drugs Sales Market Share by Region in 2019
Figure 15. Global Urinary Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Urinary Drugs Revenue Market Share by Region in 2019
Figure 17. Global Urinary Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Urinary Drugs Revenue in 2019
Figure 19. Urinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Urinary Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Urinary Drugs Sales Market Share by Type in 2019
Figure 22. Global Urinary Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Urinary Drugs Revenue Market Share by Type in 2019
Figure 24. Global Urinary Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Urinary Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Urinary Drugs Sales Market Share by Application in 2019
Figure 27. Global Urinary Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Urinary Drugs Revenue Market Share by Application in 2019
Figure 29. North America Urinary Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Urinary Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Urinary Drugs Sales Market Share by Country in 2019
Figure 32. North America Urinary Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Urinary Drugs Market Share by Type in 2019
Figure 38. North America Urinary Drugs Market Share by Application in 2019
Figure 39. Europe Urinary Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Urinary Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Urinary Drugs Sales Market Share by Country in 2019
Figure 42. Europe Urinary Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Urinary Drugs Market Share by Type in 2019
Figure 54. Europe Urinary Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Urinary Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Urinary Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Urinary Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Urinary Drugs Revenue Market Share by Region in 2019
Figure 59. China Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Urinary Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Urinary Drugs Market Share by Application in 2019
Figure 83. Latin America Urinary Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Urinary Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Urinary Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Urinary Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Urinary Drugs Market Share by Type in 2019
Figure 94. Latin America Urinary Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Urinary Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Urinary Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Urinary Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Urinary Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Urinary Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Urinary Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Urinary Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Urinary Drugs Market Share by Application in 2019
Figure 107. North America Urinary Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Urinary Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Urinary Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Urinary Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Urinary Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Urinary Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Urinary Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Urinary Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Urinary Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Urinary Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
尿道スリングの世界市場（～2026年） Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body's tissue or synthetic mesh to create a hammock-like fixture that wraps around the b…- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 尿失禁の世界市場（～2026年） Urinary incontinence is the involuntary leakage of urine. It means a person urinates when they do not want to. Control over the urinary sphincter is either lost or weakened. Urinary incontinence is a common problem that affects many people. Market Analysis and Insights: Global Urinary Incontinence M…
- 細菌性膣炎薬の世界市場（～2026年） Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis inclu…